RMC-6291
Product Specifications
CAS Number
2641998-63-0
Target
Apoptosis|||ERK|||Ras|||Kras
Related Pathways
MAPK|||Apoptosis|||GPCR/G Protein
Purity
0.9992
Bioactivity
RMC-6291 is an orally active, covalent inhibitor of KRAS G12C (ON) that forms a tri-complex within tumor cells between KRAS G12C (ON) and cyclophilin A (CypA), thereby preventing KRAS G12C (ON) from signaling via steric blockade of RAS effector binding and eliciting deep and durable suppression of RAS pathway activity in KRAS G12C tumor models [1].
Smiles
CCN1C2=C3C=C(C=C2)N4CCO[C@H](C4)C[C@@H](C(=O)N5CCC[C@H](N5)C(=O)OCC(CC3=C1C6=C(N=CC=C6)[C@H](C)OC)(C)C)NC(=O)[C@H](C(C)C)N(C)C(=O)C7(CCN(CC7)C(=O)C#CC(C)(C)N(C)C)F
Molecular Formula
C55H78FN9O8
Molecular Weight
1012.26
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1451749-01 0.02 mg (E-Coli)
Recombinant Dictyostelium discoideum Histone H2B.v1 (H2Bv1)
Ask
View Details 
MBS1451749-02 0.1 mg (E-Coli)
Recombinant Dictyostelium discoideum Histone H2B.v1 (H2Bv1)
Ask
View Details MBS1451749-03 0.02 mg (Yeast)
Recombinant Dictyostelium discoideum Histone H2B.v1 (H2Bv1)
Ask
View Details MBS1451749-04 0.1 mg (Yeast)
Recombinant Dictyostelium discoideum Histone H2B.v1 (H2Bv1)
Ask
View Details MBS1451749-05 0.02 mg (Baculovirus)
Recombinant Dictyostelium discoideum Histone H2B.v1 (H2Bv1)
Ask
View Details 
MBS1451749-06 0.02 mg (Mammalian-Cell)
Recombinant Dictyostelium discoideum Histone H2B.v1 (H2Bv1)
Ask
View Details